Peregrine Capital Management LLC Axogen, Inc. Transaction History

Peregrine Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 30, 2020	SELL	$7.35 - $10.81 $4.6 Million - $6.76 Million	-625,350 Closed	0 $0
Q1 2020 Apr 17, 2020	BUY	$8.38 - $17.34 $508,087 - $1.05 Million	60,631 Added 10.74%	625,350 $6.5 Million
Q4 2019 Jan 16, 2020	SELL	$11.18 - $18.6 $845,677 - $1.41 Million	-75,642 Reduced 11.81%	564,719 $10.1 Million
Q3 2019 Oct 16, 2019	BUY	$12.09 - $20.46 $122,882 - $207,955	10,164 Added 1.61%	640,361 $7.99 Million
Q2 2019 Jul 18, 2019	BUY	$18.5 - $25.47 $2.95 Million - $4.06 Million	159,430 Added 33.87%	630,197 $0
Q1 2019 Apr 12, 2019	BUY	$14.62 - $22.13 $529,317 - $801,216	36,205 Added 8.33%	470,767 $0
Q4 2018 Jan 17, 2019	BUY	$17.09 - $38.25 $1.93 Million - $4.32 Million	113,063 Added 35.17%	434,562 $8.88 Million
Q3 2018 Oct 18, 2018	BUY	$34.05 - $55.9 $10.9 Million - $18 Million	321,499 New	321,499 $0

163

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $534M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Peregrine Capital Management LLC with notifications on news.